The role of striatal metabotropic glutamate receptors in Parkinson's disease

被引：0
|
作者：
K. Ossowska
J. Konieczny
J. Wardas
K. Gołembiowska
S. Wolfarth
A. Pilc
机构：
[1]  Department of Neuro-Psychopharmacology,
[2] Institute of Pharmacology,undefined
[3] ,undefined
[4]  Department of Pharmacology,undefined
[5] Institute of Pharmacology,undefined
[6] and,undefined
[7]  Department of Neurobiology,undefined
[8] Institute of Pharmacology,undefined
[9] Polish Academy of Sciences,undefined
[10] Kraków,undefined
[11] Poland,undefined
来源：
Amino Acids | 2002年 / 23卷
关键词：
Keywords: Metabotropic glutamate receptors; Antiparkinsonian-like effects; Striatum;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
 The primary cause of Parkinson's disease is a loss of dopamine in the corpus striatum. It has been postulated that this effect leads to disinhibition of the striopallidal pathway and secondarily, to a functional shift towards glutamatergic stimulation. The aim of the present study was to find out whether inhibition of glutamatergic transmission at a level of metabotropic glutamate receptors (mGluRs) in the striatum may alleviate parkinsonian-like symptoms in rats.
引用
收藏
页码：193 / 198
页数：5
相关论文
共 50 条
  • [21] Metabotropic glutamate receptors : Potential pharmacological targets in Parkinson's disease treatment
    Amalric, M
    Turle-Lorenzo, N
    Lopez, S
    NEUROPHARMACOLOGY, 2005, 49 : 231 - 231
  • [22] Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease
    Masilamoni, Gunasingh J.
    Smith, Yoland
    CURRENT OPINION IN PHARMACOLOGY, 2018, 38 : 72 - 80
  • [23] NMDA-metabotropic glutamate receptors interaction in a rat model of Parkinson's disease
    Breysse, N
    Amalric, M
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S75 - S75
  • [24] Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease
    Di Menna, Luisa
    Alborghetti, Marika
    De Bartolo, Maria Ilenia
    Borro, Marina
    Gentile, Giovanna
    Zinni, Manuela
    Bologna, Matteo
    Cutrona, Carolina
    D'Errico, Giovanna
    Imbriglio, Tiziana
    Bucci, Domenico
    Merlo, Sara
    Ginerete, Roxana Paula
    Orlando, Rosamaria
    Carrillo, Federica
    Fortunato, Giorgio
    Cannella, Milena
    Sortino, Maria Angela
    Pansiot, Julien
    Baud, Olivier
    Nicoletti, Ferdinando
    Bruno, Valeria
    Simmaco, Maurizio
    Pontieri, Francesco Ernesto
    Bianchini, Edoardo
    Rinaldi, Domiziana
    de Curtis, Amalia
    De Gaetano, Giovanni
    Iacoviello, Licia
    Esposito, Teresa
    Berardelli, Alfredo
    Battaglia, Giuseppe
    NPJ PARKINSONS DISEASE, 2025, 11 (01)
  • [25] The role of striatal metabotropic glutamate receptors in degeneration of dopamine neurons: Review article
    Golembiowska, K
    Konieczny, J
    Ossowska, K
    Wolfarth, S
    AMINO ACIDS, 2002, 23 (1-3) : 199 - 205
  • [26] The role of striatal metabotropic glutamate receptors in degeneration of dopamine neurons: Review article
    K. Gołembiowska
    J. Konieczny
    K. Ossowska
    S. Wolfarth
    Amino Acids, 2002, 23 : 199 - 205
  • [27] Regulation of striatal dopamine release by metabotropic glutamate receptors
    Verma, A
    Moghaddam, B
    SYNAPSE, 1998, 28 (03) : 220 - 226
  • [28] Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease
    Duty, Susan
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (02) : 271 - 287
  • [29] Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease
    Dekundy, A
    Pietraszek, M
    Schaefer, D
    Cenci, MA
    Danysz, W
    BRAIN RESEARCH BULLETIN, 2006, 69 (03) : 318 - 326
  • [30] NMDA and metabotropic receptors regulate tyrosine phosphorylation of striatal glutamate receptors
    Orlando, LR
    Dunah, AW
    Standaert, DG
    Penney, JB
    Young, AB
    NEUROPHARMACOLOGY, 1999, 38 (10) : A33 - A33
12345